Skip to main content

Drug Interactions between Biltricide and tafenoquine

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

No interactions were found between Biltricide and tafenoquine. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Biltricide

A total of 111 drugs are known to interact with Biltricide.

tafenoquine

A total of 36 drugs are known to interact with tafenoquine.

Drug and food interactions

Moderate

praziquantel food

Applies to: Biltricide (praziquantel)

Food can enhance the levels of praziquantel in your body. To ensure maximal oral absorption, praziquantel should be administered with or immediately after a meal. This will make it easier for your body to absorb the medication. If you are receiving therapy with praziquantel you should avoid grapefruits and grapefruit juice. Grapefruit can raise the levels of praziquantel in your body and increase side effects of dizziness, abdominal discomfort, and nausea.. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor.

Moderate

tafenoquine food

Applies to: tafenoquine

Food helps with the absorption of tafenoquine into the blood stream. You should take this medication with food as directed.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer